Indian pharma companies to show healthy revenue growth of 7-9% in FY26, even as U.S. market risks loom: ICRA gopalkumarthakur@gmail.com 1 year ago Related posts: Supreme Court collegium recommends Justice Shree Chandrashekhar as Bombay High Court Chief Justice Hazarika one of the most extraordinary voices India has ever known: PM Modi Desperate bid to curry favour with RSS leadership: Congress on PM Modi’s praise for Bhagwat Educating young voters
